WO2007122721A1 - Fibres et produits dérivés pour le soulagement des symptômes de douleurs fibromusculaires - Google Patents

Fibres et produits dérivés pour le soulagement des symptômes de douleurs fibromusculaires Download PDF

Info

Publication number
WO2007122721A1
WO2007122721A1 PCT/JP2006/308392 JP2006308392W WO2007122721A1 WO 2007122721 A1 WO2007122721 A1 WO 2007122721A1 JP 2006308392 W JP2006308392 W JP 2006308392W WO 2007122721 A1 WO2007122721 A1 WO 2007122721A1
Authority
WO
WIPO (PCT)
Prior art keywords
carbon fiber
fiber
fibromyalgia
present
symptom
Prior art date
Application number
PCT/JP2006/308392
Other languages
English (en)
Japanese (ja)
Inventor
Yasuhiko Munakata
Original Assignee
Therath Medico, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therath Medico, Inc. filed Critical Therath Medico, Inc.
Priority to PCT/JP2006/308392 priority Critical patent/WO2007122721A1/fr
Priority to JP2006525407A priority patent/JPWO2007122721A1/ja
Publication of WO2007122721A1 publication Critical patent/WO2007122721A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47C—CHAIRS; SOFAS; BEDS
    • A47C27/00—Spring, stuffed or fluid mattresses or cushions specially adapted for chairs, beds or sofas
    • A47C27/12—Spring, stuffed or fluid mattresses or cushions specially adapted for chairs, beds or sofas with fibrous inlays, e.g. made of wool, of cotton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F9/00—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
    • D01F9/08—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments of inorganic material
    • D01F9/12—Carbon filaments; Apparatus specially adapted for the manufacture thereof
    • D01F9/14—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments
    • D01F9/16—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from products of vegetable origin or derivatives thereof, e.g. from cellulose acetate
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
    • A41B2400/00—Functions or special features of shirts, underwear, baby linen or handkerchiefs not provided for in other groups of this subclass
    • A41B2400/32—Therapeutic use
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D2400/00—Functions or special features of garments
    • A41D2400/32—Therapeutic use
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
    • D06M2101/40—Fibres of carbon

Definitions

  • the present invention relates to a fibromyalgia symptom-relieving fiber, a textile product, a mat, clothing, and a vest.
  • Patent Document 1 Japanese Patent Laid-Open No. 2000-160476
  • Patent Document 2 Utility Model Registration No. 3098293
  • Patent Document 3 Utility Model Registration No. 3095112
  • Patent Document 4 Japanese Unexamined Patent Application Publication No. 2004-223188
  • Non-Patent Document 1 The 81st Annual Meeting of the Kanto Branch of the Bacteriological Society of Japan
  • Non-Patent Document 2 10th Annual Meeting of the Japanese Endovascular Society Program
  • Fibromyalgia has become a problem as an unknown disease. Fibromyalgia is a disease that causes pain, numbness, etc. throughout the body or area of the body, and is accompanied by insomnia, headache, slight fever, and fatigue.
  • Table 1 shows the symptoms of fibromyalgia. [Table 1] Fibromyalgia symptoms
  • treatment methods include blocking cervical stellate ganglia by injection or low-power laser, and taking drugs such as anti-anxiety drugs, antidepressants, and antiepileptic drugs.
  • the present invention has been made paying attention to such a problem, and can be treated regardless of location, and can easily relieve the symptoms of fibromyalgia without side effects.
  • Symptoms of Means for solving the problems aimed at providing fibers, textiles, mats, clothing and vests
  • the fibromyalgia symptom alleviating fiber according to the present invention is composed of carbon fiber made of cotton.
  • the fibromyalgia symptom alleviating fiber according to the present invention is preferably processed into a sheet shape.
  • a method for forming a sheet for example, a knitting method, a non-woven fabric or other method of sandwiching between two cloths, and a method of enclosing in a cloth bag are preferable.
  • processing into a sheet it is preferable to process to a density of 1200 to 1300 gZm 2 and a thickness of about 2 to 3 mm.
  • the fibromyalgia symptom alleviating fiber according to the present invention has an effect of relieving fibromyalgia symptom by being placed as close as possible to the positions of 18 "tenderness points" on the body. is there.
  • the degree of closeness may be as small as one or two underwear or sheets that do not need to be touched directly on the skin, or just touch the “tenderness point” through the fabric.
  • Tender point exists symmetrically on both sides of the body, and when palpated at a strength of about 4kg, “not painful”, “slightly painful”, “moderately painful” and “very painful” In the four stages of "", it is the part that feels more than "a little painful”.
  • the occipital region, lower cervical vertebrae, trapezius, supraspinatus, second gastrocnemius, lateral epicondyle, buttocks, greater trochanter and knee are the characteristic “tender point” positions in fibromyalgia.
  • the occipital region with the suboccipital tendon
  • the lower cervical vertebra anterior between the 5th and 7th cervical vertebrae
  • the trapezius the middle of the upper edge
  • Supraspinous muscle origin, above the scapula spine near the inner edge
  • second gluteal muscle second rib-one costal cartilage joint, just outside the joint
  • lateral epicondyle upper 2cm distal from the Yori
  • buttocks 4 semi-upper outer side of the buttocks
  • greater trochanter posterior part of the trochanter
  • knee a pair of fluffy parts on the inside and slightly above The place is the tender point.
  • Figure 1 shows the location of the tender point.
  • fibromyalgia symptom alleviating fiber it is preferable to maintain and apply the condition simultaneously applied to all of the 18 “tenderness points” in order to enhance and sustain the symptom relief effect. . Furthermore, it is preferable to cover the whole body. However, the effect of relieving the symptoms of fibromyalgia is also observed when used on only one of the “tenderness points”. "Tender point” It may be applied to other painful places. In addition, it does not always need to be applied, and it can be used only during the daytime or only during the nighttime.
  • the fibromyalgia symptom alleviating fiber according to the present invention can be treated at any place, and can easily relieve the fibromyalgia symptom without side effects.
  • the mechanism of action of the fibromyalgia symptom relief fiber according to the present invention is unknown.
  • Carbon fiber is known to have a far-infrared radiation effect, but far-infrared radiation alone has little effect on the symptoms of fibromyalgia. It is considered a synergistic effect.
  • the fibromyalgia symptom-relieving fiber according to the present invention is obtained by impregnating and drying a treatment liquid mainly composed of wood vinegar, bamboo vinegar, or both into cotton fibers. It is preferable. In this case, bactericidal and antibacterial properties can be obtained.
  • the processing solution may contain mugwort extract.
  • immersion is preferred. In this case, it is preferable to wash the carbon fiber soaked with distilled water and then dry it.
  • the drying method vacuum drying or hot air drying is preferred.
  • the fibromyalgia symptom alleviating fiber according to the present invention is limited to carbon fiber made from cotton.
  • Carbon fibers made from cotton are preferably carbonized carbonized at a high temperature of 800 ° C or higher, preferably around 900 ° C.
  • the carbon fiber using cotton as a raw material is obtained by heating the cotton in an oxidizing atmosphere to infusibilization treatment or flame resistance treatment, and further heating in an inert gas for carbonization.
  • the activation function of carbon fiber can be improved by activation treatment that can be performed as activated carbon fiber having high adsorption ability by applying activation treatment.
  • a textile product according to the present invention is characterized by including the above-mentioned fibromyalgia symptom-reducing fiber according to the present invention.
  • the textile product according to the present invention for example, clothes, sheets, other bedding, cushions, carpets, sofa covers, etc., which are in contact with humans for a long time are preferable.
  • the fibromyalgia symptom-relieving fiber according to the present invention is preferably processed into a sheet and sandwiched between the fiber products according to the present invention. When processing into a sheet, it is preferable to process to a density of 1200 to 1300 gZm 2 and a thickness of about 2 to 3 mm.
  • the textile product according to the present invention is applied to one or more positions of 18 "tenderness points" of the body. This has the effect of alleviating the symptoms of fibromyalgia.
  • the degree to which it touches may be such that it touches the “tenderness point” through one or two thin fabrics such as underwear and sheets that do not need to touch the skin directly!
  • a mat according to the present invention is characterized in that the fibromyalgia symptom alleviating fiber according to the present invention is disposed in a range covering the occipital groin area of an adult.
  • the fibromyalgia symptom alleviating fiber according to the present invention is preferably processed into a sheet and sandwiched between the mats according to the present invention.
  • processing into a sheet it is preferable to process to a density of 120 Og to 1300 gZm 2 and a thickness of about 2 mm to 3 mm.
  • the range covering from the back of the adult to the buttocks is preferably about 50 cm x 70 cm to 75 cm x 110 cm, and particularly preferably about 55 cm x 80 cm.
  • the fibromyalgia symptom-relieving fiber according to the present invention is arranged in a range that covers the occipital force of the adult up to the buttocks. Of these, (1) the occipital region, (4) the supraspinatus, and (7) the buttocks can be covered.
  • the mat according to the present invention is supine on the mat, and the fibromyalgia symptom alleviating fiber according to the present invention is applied to the occipital region, the supraspinatus, and the buttocks, thereby reducing the symptoms of fibromyalgia. It has a mitigating effect.
  • the mat according to the present invention is prone or scoliated thereon, and the fibromyalgia symptom relief fiber according to the present invention is applied to the tender point on the front side or the tender point on the side of the body.
  • the fibromyalgia symptom relief fiber according to the present invention is applied to the tender point on the front side or the tender point on the side of the body.
  • the fibromyalgia symptom alleviating fiber according to the present invention is preferably processed into a sheet and sandwiched between the clothes according to the present invention.
  • processing into a sheet it is preferable to process to a density of 120 Og to 1300 gZm 2 and a thickness of about 2 mm to 3 mm.
  • the occipital region, lower cervical vertebrae, trapezius, supraspinatus, second gluteal muscle, lateral epicondyle, buttocks, greater trochanter and knee are 18 characteristic positions in fibromyalgia It is.
  • the garment according to the present invention is worn and the fibromyalgia symptom alleviating fiber according to the present invention is applied to the occipital region, lower cervical vertebra, trapezius, supraspinatus, second gluteal muscle, lateral epicondyle, buttocks To the greater trochanter and knee When applied, it has the effect of alleviating the symptoms of fibromyalgia.
  • the clothes according to the present invention are preferably underwear such as pants' shirts, pajamas, supporters, and scarves, but may be socks, gloves, hats, or the like.
  • the vest according to the present invention has the occipital region, the lower cervical vertebra, the trapezius, the supraspinatus, and the second ankle muscle when the fibromyalgia symptom alleviating fiber according to the present invention is worn. It is characterized by being arranged in the covered area.
  • the fibromyalgia symptom alleviating fiber according to the present invention is preferably processed into a sheet and sandwiched between the vests according to the present invention.
  • processing into a sheet it is preferable to process to a density of 120 Og to 1300 gZm 2 and a thickness of about 2 mm to 3 mm.
  • the occipital region, lower cervical vertebrae, trapezius, supraspinatus, and second gastrocnemius are 10 positions out of the 18 “tenderness points” characteristic of fibromyalgia .
  • the vest according to the present invention has a shape in which the collar is elongated in order to apply the fibromyalgia symptom relief fiber according to the present invention to those tender points when worn.
  • the collar is elongated like a muffler so that it can be wrapped around the neck.
  • the vest according to the present invention is worn, and the fibromyalgia symptom alleviating fiber according to the present invention is applied to the occipital region, lower cervical vertebra, trapezius, supraspinatus, and second gluteal muscle, so that fibromyalgia It has the effect of relieving symptoms.
  • the emissivity of the carbon fiber usable in the present invention was measured by an infrared radiometer.
  • SA200 manufactured by Minerald
  • NEC PC-98RL a data processing device
  • the test was commissioned to Kanagawa Prefectural Industrial Technology Research Institute.
  • the test consists of a density of 1200g to 1300gZm with a density of 1200g to 1300gZm 2 (sample name: knit), a carbon fiber knitted to a thickness of 2.2mm, and a cotton-like carbon fiber processed to a thickness of 2.5mm.
  • the sheet (sample name: E- 1500), the sheet (sample name: E- 200 0) of the density 1200g to 1300 g / m 2 was Karoe to a thickness of 3 millimeters carbon fibers flocculent was performed on.
  • fibromyalgia symptoms of fibromyalgia that can be treated at any place and have no side effects. It is possible to provide fibromyalgia symptom-reducing fibers, textiles, mats, clothing, and vests that can be easily relieved.
  • FIG. 5 shows a mat according to an embodiment of the present invention.
  • the mat also has a force with the mat body 1, the cover 2, and the carbon fiber sheet 3.
  • the mat body 1 is an example and has a size of 100 cm ⁇ 200 cm ⁇ 3 cm.
  • the cover 2 is sized to cover the entire mat body 1 and has a zipper 4 at the center.
  • the cover 1 is capable of inserting and removing the mat body 1 with a zipper 4 force, and the mat body 1 is housed inside.
  • a carbon fiber sheet 3 is detachably attached to the mat body 1 with a hook-and-loop fastener at the center thereof.
  • the carbon fiber sheet 3 has a size of 75 cm ⁇ 110 cm ⁇ 0.2 cm.
  • Carbon fiber sheet 3 is manufactured by heating cotton in an acidic atmosphere at a temperature of around 900 ° C to infusibilization or flameproofing, and then heating it in an inert gas to carbonize it.
  • Commercially available products (trade name: vegetable carbon fiber organ hexa 02 sheet, manufactured by i-Tech Co., Ltd.) are used.
  • FIG. 6 shows the best of the embodiment of the present invention.
  • the vest includes a vest body 5 and a carbon fiber sheet 6.
  • the best body 5 has, for example, a collar 7 having a length of about 5 cm.
  • the vest body 5 has a double fabric, and the carbon fiber sheet 6 is sewn between the fabrics.
  • the carbon fiber sheet 6 is disposed in a range of about one third of the upper portion of the vest body 5. In other words, it is installed within 10 cm from the top edge on the front side and 17 cm from the top edge on the back side.
  • Target patients This clinical study was conducted in writing for 11 FM patients (10 women, 1 man) who met the ACR's FM classification criteria and received treatment at Sendai Yutahiro Sakura Hospital. After obtaining consent to participate in the study, it was considered as a patient for examination. This clinical trial was conducted with the approval of the Taehira Sakura Hospital Ethics Committee. The average age of the patients was 39.5 ⁇ 10.0 years old (Female: 26-49 years old, Male: 35 years old). Pharmacotherapeutic treatment for target patients ⁇ Other treatment methods should be changed from one month before participation in this study to during the study.
  • Carbon fiber sheet As a carbon fiber using cotton as a raw material, a commercial product developed by i-tech Co., Ltd. (trade name: plant carbon fiber Olga hexa 02 sheet) (80cm XI 00cm) (hereinafter, Simply called “carbon fiber sheet”).
  • Test method A carbon fiber sheet was provided to the target patients, and the shoulder line was placed at the top under the bed sheet used at bedtime, and the treatment time with carbon fiber was defined as the nighttime bedtime. The patient's bedtime followed the usual lifestyle. FM pathology was assessed using a Fibromyalgia Impact Questionnaire (FIQ) ( Figure 7)
  • FIQ Fibromyalgia Impact Questionnaire
  • the therapeutic effects of carbon fiber sheets are not only improved as assessed by the FIQ index, but in the effective cases, it is possible to get out of bedside vitality, return to work, etc.
  • the effect that contributes to the improvement of sex was also recognized.
  • the carbon fiber sheet has been observed to have a maximum effect in one hour and a short time after use. It has also been observed that the treatment effect can be easily canceled by discontinuing use.
  • Carbon fiber can exert a therapeutic effect for FM in the short term, but it is difficult to say that it is a radical therapeutic effect. Therefore, carbon fiber was used for FM treatment. Continuous treatment is necessary. It is estimated that more effective FM treatment will be possible by adopting the use of carbon fiber as the basic treatment method for FM treatment and then developing drug therapy 'diet therapy / exercise therapy'.
  • FIG. 1 is an explanatory diagram showing the position of a tender point.
  • FIG. 2 is a graph showing the results of measuring emissivity with an infrared radiometer for carbon fibers usable in the present invention.
  • FIG. 3 is a graph showing the results of measuring emissivity with an infrared radiometer for carbon fibers usable in the present invention.
  • ⁇ 4 A graph showing the results of measuring the emissivity of the carbon fiber usable in the present invention with an infrared radiometer.
  • FIG. 5 is a front view showing a mat according to an embodiment of the present invention.
  • FIG. 6 is a (A) front view and (B) rear view showing a vest according to an embodiment of the present invention.
  • FIG. 7 is an explanatory diagram showing questionnaire items regarding effects on fibromyalgia.
  • FIG. 8 is a graph showing clinical effects obtained in 1 hour after use with the carbon fiber of the present invention.
  • FIG. 9 is a graph showing the clinical effect obtained by using the carbon fiber of the present invention for one week.
  • FIG. 10 is a graph showing the clinical effect obtained by using the carbon fiber of the present invention for one week.
  • FIG. 11 is a graph showing the clinical effect obtained by using the carbon fiber of the present invention for 2 weeks.
  • FIG. 12 is a graph showing the clinical effect obtained by using the carbon fiber of the present invention for 2 weeks. 13] A graph showing the result of discontinuation of use of the carbon fiber of the present invention. Explanation of symbols

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nonwoven Fabrics (AREA)
  • Outer Garments And Coats (AREA)
  • Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Inorganic Fibers (AREA)

Abstract

La présente invention a pour objet une fibre et des produits fibreux tels qu'un tapis, des vêtements et une veste qui sont utilisables en thérapie en tout lieu, ne présentent pas d'effets secondaires et peuvent aisément soulager les symptômes de douleurs fibromusculaires. La présente invention a également pour objet une fibre destinée à soulager les symptômes de douleurs fibromusculaires qui comprend une fibre de carbone produite à partir du coton. La présente invention a en outre pour objet une veste conçue de façon à ce que la fibre destinée à soulager les symptômes de douleurs fibromusculaires soit localisée dans les zones couvrant la région occipitale de la tête, les vertèbres cervicales inférieures, le muscle trapèze, le muscle supra-épineux et le second muscle costal de la personne qui la porte.
PCT/JP2006/308392 2006-04-21 2006-04-21 Fibres et produits dérivés pour le soulagement des symptômes de douleurs fibromusculaires WO2007122721A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/JP2006/308392 WO2007122721A1 (fr) 2006-04-21 2006-04-21 Fibres et produits dérivés pour le soulagement des symptômes de douleurs fibromusculaires
JP2006525407A JPWO2007122721A1 (ja) 2006-04-21 2006-04-21 線維筋痛症の症状緩和用繊維および繊維製品

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2006/308392 WO2007122721A1 (fr) 2006-04-21 2006-04-21 Fibres et produits dérivés pour le soulagement des symptômes de douleurs fibromusculaires

Publications (1)

Publication Number Publication Date
WO2007122721A1 true WO2007122721A1 (fr) 2007-11-01

Family

ID=38624649

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/308392 WO2007122721A1 (fr) 2006-04-21 2006-04-21 Fibres et produits dérivés pour le soulagement des symptômes de douleurs fibromusculaires

Country Status (2)

Country Link
JP (1) JPWO2007122721A1 (fr)
WO (1) WO2007122721A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106724350A (zh) * 2017-01-18 2017-05-31 李力 一种双温控床垫

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11206539A (ja) * 1998-01-27 1999-08-03 E Tec:Kk 炭素繊維を用いた遠赤外線シーツ
JP2000160476A (ja) * 1998-11-30 2000-06-13 E Tec:Kk 炭素繊維の製造方法およびそれによって得られた炭素繊維
JP2001516404A (ja) * 1997-03-14 2001-09-25 メシェ−ブガッティ 炭素繊維製活性布帛の製造法
JP2001342688A (ja) * 2000-06-01 2001-12-14 Nisseki House Industry Co Ltd 建材等用炭化素材、およびその製造方法
JP2003247163A (ja) * 2002-02-20 2003-09-05 Yutaka Kawasaki 電磁波吸収体、およびその製造方法
JP2004024481A (ja) * 2002-06-25 2004-01-29 Yoichi Kadokami 抗菌性医用材料

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001516404A (ja) * 1997-03-14 2001-09-25 メシェ−ブガッティ 炭素繊維製活性布帛の製造法
JPH11206539A (ja) * 1998-01-27 1999-08-03 E Tec:Kk 炭素繊維を用いた遠赤外線シーツ
JP2000160476A (ja) * 1998-11-30 2000-06-13 E Tec:Kk 炭素繊維の製造方法およびそれによって得られた炭素繊維
JP2001342688A (ja) * 2000-06-01 2001-12-14 Nisseki House Industry Co Ltd 建材等用炭化素材、およびその製造方法
JP2003247163A (ja) * 2002-02-20 2003-09-05 Yutaka Kawasaki 電磁波吸収体、およびその製造方法
JP2004024481A (ja) * 2002-06-25 2004-01-29 Yoichi Kadokami 抗菌性医用材料

Also Published As

Publication number Publication date
JPWO2007122721A1 (ja) 2009-08-27

Similar Documents

Publication Publication Date Title
Sau-Fun et al. Development of medical garments and apparel for the elderly and the disabled
Curteza et al. Designing functional clothes for persons with locomotor disabilities
US20100050316A1 (en) Synthetic woven patient gown for preventing and reducing skin wounds
US20090312684A1 (en) Underpad for preventing and reducing skin wounds
US20090308404A1 (en) Fabrics for preventing and reducing skin wounds
Yu Achieving comfort in intimate apparel
JP5642173B2 (ja) 皮膚創傷を予防および低減するための改良された布
WO2007122721A1 (fr) Fibres et produits dérivés pour le soulagement des symptômes de douleurs fibromusculaires
JP2009127157A (ja) 慢性頭痛の治療用及び／又は予防用素材、並びにその用途
CN202407086U (zh) 一种能量热灸衫
US20130172968A1 (en) Therapuedic undergarments/garments for treatment of Fibromyalgia (FM)
CN210076654U (zh) 一种预防压疮短裤
Jung et al. Actual conditions of functional clothing development for the elderly-Based on patent analysis of functional products
Rudolf et al. Protective Garments for Wheelchair Users
TW202002923A (zh) 片材之引發愉快感覺性能之評價方法及引發愉快感覺之片材
CN201557576U (zh) 保健护腰
Skodova et al. Performance of textile materials for the needs of children with skin problems
JPWO2008044785A1 (ja) 脳血流改善用素材及びその用途
CN210203428U (zh) 一种多功能的蕲艾养生棉袄
Choi et al. The relationship between practice in lymphedema self-care management and health-related quality of life in breast cancer patients with mastectomy
Glovinsky et al. Sleepwear with lateralized thermal properties for the treatment of sleep disturbance in women
CN211356613U (zh) 一种改善血液循环的下肢保暖装置
CN211672597U (zh) 一种卧床护理服
CN102121170A (zh) 一种结香中含功效成分纤维的制备及其用途
CN106945357A (zh) 一种防水保暖的艾绒功能面料

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2006525407

Country of ref document: JP

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06732200

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06732200

Country of ref document: EP

Kind code of ref document: A1